文献速递胸部CTPET

是否存在可预测胸膜间皮瘤不可切除性的影像特征

Are there features that can predict the unresectability of pleural mesothelioma?
PubMed 文献 · Eur Radiol · 2024-08-15

回顾性评估133例术前CT和/或PET/CT上22个描述性影像特征,比较可切除与不可切除胸膜间皮瘤;52%可切除、48%不可切除,胸膜厚度测量、胸膜外间隙消失、纵隔侵犯等为不可切除性的显著预测因子,多变量模型AUC>0.8,最佳模型AUC达0.876和0.879。

要点

  • 胸膜外间隙消失、纵隔侵犯及胸膜最大厚度是预测胸膜间皮瘤不可切除的重要影像特征。
  • 多变量模型诊断性能强,AUC>0.8,最佳模型AUC分别为0.876和0.879。
  • 术前更准确判断不可切除性可能避免不必要手术并促使尽早开始非手术治疗。

核心结论

  • 所选临床和影像特征(包括胸膜厚度测量)似乎为胸膜间皮瘤不可切除性的强预测因子。

研究设计与样本

  • 回顾性研究,纳入133例推测可切除并接受手术的胸膜间皮瘤患者,术前评估CT和/或PET/CT上的22个描述性影像特征。

关键影像表现/征象

  • 胸膜厚度模式(p<0.0001)和胸膜厚度程度(p=0.033)在可切除与不可切除肿瘤间差异显著。
  • 胸膜外间隙消失(p<0.0001)、纵隔侵犯(p<0.0001)、肺侵犯(p=0.004)、延伸至膈下间隙(p=0.0004)为显著预测因子。
  • 代表广泛膈肌接触和/或胸壁受累的组合变量(p=0.002)及纵隔侵犯组合变量(p<0.0001)为显著预测因子。

诊断标准与关键数值

  • 胸膜最大厚度及三个胸部水平(上、中、下)胸膜厚度总和按国际肺癌研究协会(IASLC)提供的截断值分层。
  • 单变量分析中所有胸膜厚度测量(p<0.05)、临床T分期(p<0.0001)、石棉暴露(p=0.005)、新辅助治疗(p=0.001)为显著预测因子。
  • 多变量分析所有模型AUC>0.8;最佳模型一包含上层最大胸膜厚度、胸膜外间隙消失和纵隔浸润,AUC=0.876。
  • 最佳模型二整合临床变量和影像评估(通过临床T分期),AUC=0.879。

临床应用与阅片要点

  • 原文结论指出,所选临床和影像特征似乎为胸膜间皮瘤不可切除性的强预测因子。
  • 原文临床相关性声明指出,术前评估中更准确预测不可切除性可能避免不必要手术并促使尽早开始非手术治疗。
  • 原文要点指出,更准确的术前分期将帮助临床医生和患者选择最合适的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The current clinical staging of pleural mesothelioma (PM) is often discordant with the pathologic staging. This study aimed to identify clinical and radiological features that could help predict unresectability in PM.

METHODS: Twenty-two descriptive radiologic features were retrospectively evaluated on preoperative computed tomography (CT) and/or positron emission tomography/CT (PET/CT) performed in patients with presumably resectable PM who underwent surgery. Measurements of maximum and sum pleural thickness at three levels of the thorax (upper, middle, and lower) were taken and stratified based on the cutpoints provided by the International Association for the Study of Lung Cancer (IASLC). Clinical and radiological features, including clinical-stage, were compared between resectable and unresectable tumors by univariate analysis and logistic regression modeling.

RESULTS: Of 133 patients, 69/133 (52%) had resectable and 64/133 (48%) had unresectable PM. Asbestos exposure (p = 0.005), neoadjuvant treatment (p = 0.001), clinical T-stage (p < 0.0001), all pleural thickness measurements (p < 0.05), pleural thickness pattern (p < 0.0001) and degree (p = 0.033), lung invasion (p = 0.004), extrapleural space obliteration (p < 0.0001), extension to subphrenic space (p = 0.0004), and two combination variables representing extensive diaphragmatic contact and/or chest wall involvement (p = 0.002) and mediastinal invasion (p < 0.0001) were significant predictors at univariate analysis. At multivariable analysis, all models achieved a strong diagnostic performance (area under the curve (AUC) > 0.8). The two best-performing models were one that included the upper-level maximum pleural thickness, extrapleural space obliteration, and mediastinal infiltration (AUC = 0.876), and another that integrated clinical variables and radiological assessment through the clinical T-stage (AUC = 0.879).

CONCLUSION: Selected clinical and radiologic features, including pleural thickness measurements, appear to be strong predictors of unresectability in PM.

CLINICAL RELEVANCE STATEMENT: A more accurate prediction of unresectability in the preoperative assessment of patients with pleural mesothelioma may avoid unnecessary surgery and prompt initiation of nonsurgical treatments.

KEY POINTS: About half of pleural mesothelioma patients are reported to receive an incorrect disease stage preoperatively. Eleven features identified as predictors of unresectability were included in strongly performing predictive models. More accurate preoperative staging will help clinicians and patients choose the most appropriate treatments.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Mayoral M, Araujo-Filho JAB, Tan KS, et al. Are there features that can predict the unresectability of pleural mesothelioma? Eur Radiol. 2024. PMID: 39143249. doi:10.1007/s00330-024-10963-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。